Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1989 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1.
Lancet Diabetes Endocrinol. 2023.
PMID: 36738751
Free PMC article.
Clinical Trial.
Stimulation of fibroblast proliferation by thrombospondin.
Phan SH, Dillon RG, McGarry BM, Dixit VM.
Phan SH, et al. Among authors: dillon rg.
Biochem Biophys Res Commun. 1989 Aug 30;163(1):56-63. doi: 10.1016/0006-291x(89)92098-6.
Biochem Biophys Res Commun. 1989.
PMID: 2673242
Free article.
Item in Clipboard
Cite
Cite